Non-functioning pituitary microadenoma in children and adolescents: Is follow-up with diagnostic imaging necessary?

Endocrine. 2023 Jan;79(1):152-160. doi: 10.1007/s12020-022-03212-7. Epub 2022 Oct 17.

Abstract

Purpose: No consensus exists regarding follow-up recommendations for suspected pituitary microadenoma in children. To address this knowledge gap, we investigated the growth potential of pituitary solid and cystic lesions <10 mm in children and evaluated the accuracy of magnetic resonance imaging (MRI) measurements.

Methods: The children included were <18 years at first pituitary MRI and radiologically diagnosed with a non-functioning microadenoma or cyst <10 mm. Lesion size at first and latest MRI as well as all individual MRI examinations were re-evaluated.

Results: In total, 74 children, median age 12 years (range 3-17), had a non-functioning microadenoma, probable microadenoma, or cyst. Of these, 55 underwent repeated MRI (median 3, range 2-7) with a median follow-up of 37 months (range 4-189). None of the pituitary lesions without hormonal disturbances increased significantly during follow-up. Two radiologists agreed that no lesion could be identified in 38/269 (14%) MRI examinations, and in 51/231 (22%) they disagreed about lesion location. In 34/460 (7%) MRI measurements size differed >2 mm, which had been considered significant progression.

Conclusion: Non-functioning pituitary microadenoma in children has small size variations, often below the spatial resolution of the scanners. We suggest lesions <4 mm only for clinical follow-up, lesions 4-6 mm for MRI after 2 years and ≥7 mm MRI after 1 and 3 years, with clinical follow-up in between. If no progression, further MRI should only be performed after new clinical symptoms or hormonal disturbances.

Keywords: Children; Follow-up; MRI; Pituitary cyst; Pituitary microadenoma.

MeSH terms

  • Adenoma* / diagnostic imaging
  • Adolescent
  • Child
  • Child, Preschool
  • Cysts*
  • Follow-Up Studies
  • Humans
  • Magnetic Resonance Imaging / methods
  • Pituitary Neoplasms* / pathology